BUZZ-VBI Vaccines Inc: To be acquired by SciVac Therapeutics

Mon Oct 26, 2015 12:04pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Vaccine developer VBI's shares up 11.5 pct at $2.66

** 421,266 shares changed hands by 11:55 a.m. ET, more than 115 times their 25-day average

** SciVac Therapeutics Inc to buy VBI with VBI shareholders receiving shares, options, warrants of SciVac representing 46 pct of combined company

** Combined company to have licensed hepatitis B vaccine and a pipeline of vaccine candidates

** Up to Friday's close, stock had fallen 30 pct this year